Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Moscow expertise validates Narconon program model
  • USA - English


News provided by

Narconon International

Nov 11, 2014, 08:00 ET

Share this article

Share toX

Share this article

Share toX

One to Three Years After Completing the Narconon Moscow program
One to Three Years After Completing the Narconon Moscow program
Youtube
Youtube

(PRWEB) November 11, 2014 -- Narconon International recently released, in its first English translation from the original Russian, a medical expertise and evaluation of the Narconon drug rehabilitation program delivered by centers in Moscow, Russian Federation, between 1995 and 1998. The two senior contributors were Dr. Yuri Gurochkin, Professor in the Department of Criminology, Moscow Law Institute, and Dr. N. N. Grigoriev, at the time of the paper Senior Lecturer in Criminology, University of Military Defense, Ministry of Interior Affairs.

The doctors studied the cases of 32 randomly selected Narconon Moscow students. Prior to enrolling in Narconon, these students had been injecting opiate drugs or using methamphetamine. All of them had Hepatitis C histories. “Medical examination of patients before and after the program,” says the paper, “shows a considerable improvement of their physical and psychological condition.” Further, the authors state in the paper’s conclusion, “the program…provides a full solution of the problems related to drug abuse.”

Of the 32 Narconon students studied in depth, 87% had been using drugs between 3 to more than 5 years. They ranged in age from 16 to 25 years old. After graduation, nearly half, the paper says, had either found work or returned to school. Eight students decided to continue to study at Narconon Moscow and took on staff positions. All of these 32 had lived stably drug-free lives after the Narconon program.

The expertise also included the results of an informal abstinence survey of the graduates. Of 158 persons who enrolled in one of the Narconon centers in or near Moscow between 1995 and 1998, the paper states, 113 were found to be drug-free from one to three years after graduation -- a 72% drug abstinence rate. This drug-free statistic parallels others tabulated in a Narconon compilation of 40 years of studies, evaluations, and Routine Outcome Monitoring post-graduation surveys of programs both in and outside prison, from Sweden to Berlin, Moscow to Mexico, and across the United States.

Leonid Gedko was one of those in the Moscow case study who chose to continue his Narconon studies after graduation and then joined staff. He is still living drug and crime-free 15 years later. In a recent interview, Gedko had strong praise for Narconon. In the late 1990’s, he remembers, drug abuse was skyrocketing. UNODC statistics report a 400% increase in per capita drug abuse between 1995 and 1998.* Gedko said that he personally knew people who had died of AIDs. His own life was a wreck, he said, before he enrolled in Narconon’s social education model program. “I was totally irresponsible, criminal and very sick. My nervous system was trashed. I was sick with hangover or drug crash every day. I was a madman.” But despite 10 earlier failures with other drug rehab programs, Gedko again found hope, he said, with the help of the Narconon life skills courses. “My greatest gains,” he reported, “were at the emotional and mental level. I graduated with the ability to achieve my goals. And I found a lovely wife, with whom I am still happily married.”

The Narconon network of drug rehab centers now includes four in Russia and one in Ukraine, as well as 12 drug education and prevention centers in Eastern Europe and the CIS.

The authors of the 1998 Moscow expertise also speak out strongly against what they call “the popular myth that drug addiction is absolutely incurable.” Effective treatment, the authors state, would “require treatment should be complex and include not only purification of the organism from toxins, but also restoration of personal moral values, i.e. the ability to differentiate between good and bad, virtue and vice, as well as to communicate with people without discomfort.” The paper goes on to describe in detail the Narconon methodology, based on the works of humanitarian and author L. Ron Hubbard, which strives to achieve just that moral renaissance in its students. The expertise decries the pro-drug information campaign of “cool magazines” of the time which instilled in youth the false concepts of “light” and “heavy” drugs. “Out of 100 drug addicts who are on the needle, 95 first tried marijuana,” state the Russian authors.

For more information on the Narconon program, please visit http://www.narconon.org. The Moscow expertise can be found in Russian and English at http://www.narconon.org/about-narconon/moscow-expertise-on-rehab-program.html.

Clark Carr, Narconon International, http://www.narconon.org, +1 323-962-2404, [email protected]

Modal title

Leonid Gedko, Narconon Moscow Program Graduate
Leonid Gedko, Narconon Moscow Program Graduate
Narconon Moscow Center
Narconon Moscow Center
Leonid Gedko, Narconon Moscow Program Graduate Narconon Moscow Center

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.